Concepedia

Author

Luciano Ibba

IRCCS Humanitas Research HospitalORCID

Also Known As

Ibba, Luciano, L. Ibba, Luciano Ibba

84

Publications

880

Citations

18

H-Index

10

Concepts

All Affiliations

IRCCS Humanitas Research HospitalHumanitas UniversityIstituti di Ricovero e Cura a Carattere ScientificoFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoIRCCS Policlinico San Donato
LI

About

Luciano Ibba is an author at IRCCS Humanitas Research Hospital specializing in dermatology, medicine, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

75

2

Allergy

1

1

21

3

Allergy Medicine

1

1

21

4

Immunology

1

1

14

5

Rheumatology

1

1

21

Luciano Ibba

×

23

Publications

552

Citations

15

H-Index

YearCitations

Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)

Luigi Gargiulo, Alessandra Narcisi, Luciano Ibba,

Frontiers in Medicine

2023

55

Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis)

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli,

Frontiers in Immunology

2024

43

Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—<scp>IL PSO</scp> (<scp>Italian landscape psoriasis</scp>)

Alessandra Narcisi, Mario Valenti, Luigi Gargiulo,

Journal of the European Academy of Dermatology and Venereology

2022

41

Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series

Luigi Gargiulo, Luciano Ibba, Giulia Pavia,

Journal of Dermatological Treatment

2023

39

Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study

Luigi Gargiulo, Luciano Ibba, Giulia Pavia,

Dermatology and Therapy

2022

35

Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104‐week multicenter retrospective study – <scp>IL PSO</scp> (<scp>ITALIAN LANDSCAPE PSORIASIS</scp>)

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli,

Journal of the European Academy of Dermatology and Venereology

2023

32

Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience—IL PSO (Italian Landscape Psoriasis)

Diego Orsini, Piergiorgio Malagoli, Anna Balato,

Dermatology Practical & Conceptual

2024

30

Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli,

Dermatology and Therapy

2024

29

Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study

Luigi Gargiulo, Luciano Ibba, Andrea Cortese,

Dermatology and Therapy

2023

28

Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis)

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli,

Frontiers in Medicine

2023

27

Page 1